Biotechnology and Digital Health Advancements in the 21st Century: A Case Study on the Adoption of Telemedicine for Managing Chronic Diseases

Biotechnology and digital health represent dynamic and transformative domains with the potential to reshape the healthcare landscape. Biotechnology harnesses the power of living organisms and their components to yield valuable products and processes, while digital health leverages digital technologies to enhance health and healthcare delivery. This chapter delves into the confluence of biotechnology and digital health, shedding light on the profound advancements and challenges in the twenty-first century. In addition to this exploration, we will present a compelling case study illustrating the adoption of telemedicine for managing chronic diseases, facilitated by synthetic patient data generated through Synthea™. The narrative will encompass the role of biotechnology in digital health, encompassing genetic engineering, gene editing, and synthetic biology. We will also explore how digital technologies, including mobile health applications, telemedicine, and wearable devices, are seamlessly integrated to elevate patient care. Furthermore, this chapter will take a comprehensive look at the ethical and regulatory dimensions that surround the use of biotechnology and digital health technologies within the healthcare sector. Through the inclusion of the case study, we aim to provide a tangible, real-world illustration of the profound impact and potential ethical considerations inherent to this intersection of innovation.